LISA SUENNEN

Lisa Suennen serves as a highly respected Venture Partner at Aphelion Capital, where she plays a pivotal role in shaping the firm's investment strategy within the dynamic healthcare sector. Her work at Aphelion Capital centers on identifying and investing in groundbreaking companies across digital health, healthcare IT, medical devices, and life sciences. With a keen eye for disruptive innovation, Lisa seeks out ventures that promise to enhance patient care, improve operational efficiencies, and redefine the future of healthcare delivery.

Before joining Aphelion Capital, Lisa built an impressive career spanning several influential roles within the venture capital and healthcare industries. She was a Senior Managing Director at GE Ventures, leading their healthcare investing efforts and fostering strategic partnerships with innovative startups. Prior to GE Ventures, Lisa co-founded and served as a Managing Partner at Psilos Group, a healthcare-focused venture capital firm, where she spent over a decade investing in and building successful healthcare technology and services companies. Her tenure at Psilos Group established her as a leading voice and investor in the evolving healthcare landscape.

Lisa's extensive background also includes significant experience in strategic advisory and operational roles, providing her with a comprehensive understanding of the challenges and opportunities within the healthcare ecosystem. She is widely recognized for her thought leadership, frequently speaking at industry conferences and contributing articles on healthcare innovation, venture capital trends, and the intersection of technology and medicine. Her insights are highly valued by entrepreneurs and investors alike, making her a sought-after mentor and advisor.

Throughout her career, Lisa has been instrumental in the growth and success of numerous companies, though specific public "notable investments" are often attributed to the funds she managed rather than individual credit. Her investment philosophy emphasizes not just financial returns, but also the potential for positive societal impact through healthcare advancements. She is known for her strategic approach to portfolio management, working closely with founders to navigate market complexities, scale operations, and achieve sustainable growth. Her commitment to fostering innovation and driving meaningful change makes her an invaluable asset to Aphelion Capital and the broader healthcare investment community.